Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 1
2003 1
2011 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
Allen UD, Kirby MA, Goeree R. Allen UD, et al. Pediatr AIDS HIV Infect. 1997 Feb;8(1):4-11. Pediatr AIDS HIV Infect. 1997. PMID: 11361510
A decision analytic structure was used for the evaluation of cost-effectiveness. The decision tree involved two options. In option A:r-HuEPO, subjects receive r-HuEPO three times weekly at home for 1 year, whereas in B:no r-HuEPO, transfusions are given on a …
A decision analytic structure was used for the evaluation of cost-effectiveness. The decision tree involved two options. In option A:r …
The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada.
Sheingold S, Churchill D, Muirhead N, Laupacis A, Labelle R, Goeree R. Sheingold S, et al. Soc Sci Med. 1992 May;34(9):983-91. doi: 10.1016/0277-9536(92)90129-e. Soc Sci Med. 1992. PMID: 1631611
Recombinant human erythropoietin (r-HuEPO) is an established and effective therapy for anemia related to end stage renal disease. ...The therapy's impact on overall medical care expenditures for these patients remains uncertain, however. In this study, we examine the costs …
Recombinant human erythropoietin (r-HuEPO) is an established and effective therapy for anemia related to end stage renal disease. ... …